COVID-⁠19 Switzerland

The chart shows the distribution of laboratory-⁠confirmed hospitalisations by age group with the corresponding vaccination status.

Three vaccines for the prevention of COVID-⁠19 are currently authorised for use in Switzerland and Liechtenstein. According to the vaccination recommendation of the FOPH/NITAG vaccination recommendation, to have full vaccine protection, two doses of the Moderna vaccine (Spikevax®) or Pfizer/BioNTech vaccine (Comirnaty®) are required, or one dose following a documented recent SARS-⁠CoV-⁠2 infection. For Johnson & Johnson (Covid-⁠19 Vaccine Janssen®), a single dose of vaccine is required to be deemed fully vaccinated. Those who are fully vaccinated against COVID-⁠19, but who have not yet had a booster vaccination are still deemed to be fully vaccinated. The efficacy of the vaccines available in Switzerland is very high. They provide effective protection against symptomatic infection, in particular severe forms of the disease, and they reduce the risk of transmission. However, this does not mean that those who are fully vaccinated (with or without a booster vaccination) cannot become infected, as no vaccine provides 100% protection.

We have been collecting data on vaccination status since the end of January 2021. It is based on information that doctors and hospitals deliver to us as part of the reporting requirement. For hospitalisations and deaths in connection with a laboratory-⁠confirmed SARS-⁠CoV-⁠2 infection, they also transmit the vaccination status in addition to the clinical information.

The information on incidence is per 100,000 inhabitants with the corresponding vaccination status of («fully vaccinated», «fully vaccinated with booster vaccination», «partially vaccinated» and «not vaccinated»). The calculation is based on the total population.

Please note when evaluating the cases by vaccination status that according to the vaccination strategy, older people and those at especially high risk were vaccinated earlier.